BR9807920A - Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência - Google Patents

Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência

Info

Publication number
BR9807920A
BR9807920A BR9807920-4A BR9807920A BR9807920A BR 9807920 A BR9807920 A BR 9807920A BR 9807920 A BR9807920 A BR 9807920A BR 9807920 A BR9807920 A BR 9807920A
Authority
BR
Brazil
Prior art keywords
dementia
subject
preventing
treating
processes
Prior art date
Application number
BR9807920-4A
Other languages
English (en)
Inventor
Philip Needleman
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of BR9807920A publication Critical patent/BR9807920A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"PROCESSOS PARA TRATAMENTO DE UMA DEMêNCIA EM UM SUJEITO E PARA PREVENçãO DE UMA DEMêNCIA". Esta invenção refere-se ao uso de inibidores de ciclo-oxigenase-2 ou de seus derivados na prevenção e no tratamento de demência. Em particular, a invenção descreve o processo de prevenção e de tratamento de demência em um sujeito, compreendendo o citado processo o tratamento do sujeito com uma quantidade terapeuticamente efetiva de um composto de fórmula (I)] na qual R^ 2^, R^ 3^ e R^ 4^ são como o descrito no relatório descritivo.
BR9807920-4A 1997-04-03 1998-03-30 Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência BR9807920A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4391697P 1997-04-03 1997-04-03
PCT/US1998/006143 WO1998043648A1 (en) 1997-04-03 1998-03-30 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia

Publications (1)

Publication Number Publication Date
BR9807920A true BR9807920A (pt) 2000-02-22

Family

ID=21929578

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807920-4A BR9807920A (pt) 1997-04-03 1998-03-30 Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência

Country Status (13)

Country Link
EP (1) EP0971714B1 (pt)
JP (1) JP2002514208A (pt)
AT (1) ATE225660T1 (pt)
AU (1) AU725697B2 (pt)
BR (1) BR9807920A (pt)
CA (1) CA2285434A1 (pt)
DE (1) DE69808607T2 (pt)
DK (1) DK0971714T3 (pt)
ES (1) ES2185154T3 (pt)
HK (1) HK1024872A1 (pt)
PT (1) PT971714E (pt)
WO (1) WO1998043648A1 (pt)
ZA (1) ZA982808B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727238B2 (en) 1998-06-11 2004-04-27 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
US6294558B1 (en) 1999-05-31 2001-09-25 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420616D0 (en) * 1994-10-12 1994-11-30 Merck Sharp & Dohme Method, compositions and use
NZ336428A (en) * 1993-11-30 2005-02-25 G use of substituted pyrazolyl benzosulphonamides to treat inflammation
US5486534A (en) * 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
US5696143A (en) * 1994-09-20 1997-12-09 Talley; John J. Benz G! indazolyl derivatives for the treatment of inflammation
US5547975A (en) * 1994-09-20 1996-08-20 Talley; John J. Benzopyranopyrazolyl derivatives for the treatment of inflammation
US5643933A (en) * 1995-06-02 1997-07-01 G. D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
WO1996038418A1 (en) * 1995-06-02 1996-12-05 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
EP0833622B8 (en) * 1995-06-12 2005-10-12 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
US5700816A (en) * 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
CA2224563A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
RO121338B1 (ro) * 1996-04-12 2007-03-30 G.D. Searle & Co. Derivaţi de benzensulfonamidă, procedeu de preparare a acestora, compoziţie farmaceutică şi utilizarea ca inhibitori de cox-2

Also Published As

Publication number Publication date
DE69808607T2 (de) 2003-06-26
DK0971714T3 (da) 2002-11-04
DE69808607D1 (de) 2002-11-14
WO1998043648A1 (en) 1998-10-08
AU6590498A (en) 1998-10-22
EP0971714A1 (en) 2000-01-19
HK1024872A1 (en) 2000-10-27
JP2002514208A (ja) 2002-05-14
ZA982808B (en) 1999-04-06
PT971714E (pt) 2002-12-31
EP0971714B1 (en) 2002-10-09
ES2185154T3 (es) 2003-04-16
ATE225660T1 (de) 2002-10-15
AU725697B2 (en) 2000-10-19
CA2285434A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
EP0931788A3 (en) Metalloprotease inhibitors
ATE225351T1 (de) Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel
TR200200068T2 (tr) Nematisital triflüorobütenler
BRPI0307351B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
AP9901478A0 (en) Compounds for the treatment of ischemia.
ES2196630T3 (es) Isotiazolcarboxiamidas y su empleo para la proteccion de las plantas.
NO992821L (no) Ketobenzamider som calpain-inhibitorer
ATE217865T1 (de) Verbindungen zur hemmung von phosphodiesrerase iv
BR9914390B1 (pt) benzoil-ciclohexano-dionas, agentes herbicidas apresentando as mesmas, processo para o combate de plantas indesejadas e aplicação dos referidos compostos.
UY25322A1 (es) Compuestos de tiourea y benzamida,composiciones y metodos para tratar y prevenir enfermedades inflamatorias y aterosclerosis
AP2001002205A0 (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
NO942065D0 (no) Fosfinyloksymetylketoner som interleukin-1 yminhibitorer
CO5261493A1 (es) Procedimiento y compuestos para la inhibicion de la mrp1
WO1998036730A3 (de) Zubereitungen für die behandlung von rosacea
BR9713207A (pt) Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz
BR9915031A (pt) Processos e composições para a inibição de polimerização de hidrocarbonetos etilenicamente insaturados
BR0011339A (pt) Composto, uso, e processo para preparar o mesmo, composição farmacêutica, e, método para tratar uma condição de doença mediada por metaloproteinase
PT941975E (pt) Cimento para injeccao contendo inibidores de corrosao
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
NO20003828L (no) 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepin-3-hydroksamsyrer som matriks-metalloproteinase inhibitorer
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases
BR9807920A (pt) Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência
AP2002002651A0 (en) Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
ATE267018T1 (de) Verwendung von peptidverbindungen zur behandlung von sle
AP2002002493A0 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007.